Interferon alfacon-1

Phase 3Small molecule

Astellas

Interferon alfacon-1 is one of 54 small molecule programs targeting Hepatitis C. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hepatitis CActive, not recruiting

InfluenzaActive, not recruiting

Hepatitis CPhase 3

Active, not recruiting

InfluenzaPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

1053 competitors in Influenza

#DrugCompanyPhaseTrials

Fluzone

Sanofi

Preclinical

16 2

Interferon alfacon-1

Astellas

Phase 3

1 3

Fluzone

GSK

Preclinical

37 4

Crestor

AstraZeneca

Preclinical

1 5

Avigan

AAppili Therapeutics Inc.

Preclinical

6 6

Quadrivalent Influenza Vaccine

Sanofi

Preclinical

30 7

COMIRNATY

Pfizer

Preclinical

1 8

Antihistamine

Arrowhead Pharmaceuticals

Preclinical

1 9

Focetria

CChiltern Pesquisa Clinica Ltda

Preclinical

1 10

PD-1/PD-L1 Inhibitors

CChuangzhen Chen

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hepatitis C1 trial

Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C

Completed· Astellas logo

Astellas·Phase 3·NCT00239252

Influenza1 trial

Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza

Unknown status·UUniversity Health Network, Toronto·Phase 1/2·NCT01227798·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Interferon alfacon-1. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Interferon alfacon-1 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Interferon alfacon-1. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Astellas company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Astellas

Interferon alfacon-1

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hepatitis C1 trial

Influenza1 trial

References

Drug Info

Quick Facts

Related News